Stereotactic Body Radiotherapy for the Treatment of Locally Advanced Pancreatic Cancer and Colorectal Liver Metastasis
A session from the Radiosurgery Society SRS/SBRT Scientific Meeting 2014 presented by:
Joseph Herman, MD, MSc
Albert C. Koong, MD, PhD
This course, which has been accredited by the American Board of Radiology (ABR) for Self-Assessment Module (SAM) maintenance of certification credit for physicians, is available from August 27, 2014, through 11:59 p.m. Eastern time on December 31, 2021.
In order to earn credit for this course, participants must:
Learners must listen to each self-directed audio recording while following along with the visual slides/read the articles.
Pass the post-test with a score of 75% or higher.
Complete an evaluation form to receive a certificate of completion.
Participate in the entire activity as partial credit is not available.
If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
The use of stereotactic body radiotherapy (SBRT) for the treatment of pancreatic cancer and liver metastases is continuously evolving. SBRT has been shown to be effective for the local control of locally advanced, unresectable pancreatic cancer in both the neo-adjuvant and adjuvant setting. SBRT has also been shown to be effective for local control of liver metastases where the primary disease is under control or undergoing treatment. There is a need to improve therapy for the local control of pancreatic cancer and liver metastasis and SBRT may be a viable treatment option for selective patients. The optimal SBRT dose, fractionation regimens and integration with chemotherapy and biologic agents needs to be further defined to maximize the therapeutic benefits.
This program is designed to meet the needs of radiation oncologists and residents-in-training with interests in SBRT for the treatment of pancreatic tumors and colorectal liver metastases.
Explain the basic principles of SBRT and the rationale for the use of SBRT in the treatment of locally advanced pancreatic cancer and colorectal liver metastasis through evidence-based literature.
Describe the patient selection for SBRT for the treatment of locally advanced pancreatic cancer and colorectal liver metastasis.
Understand the role of imaging in treatment planning of SBRT and describe patient set-up for SBRT delivery.
Discuss the principles of treatment planning to deliver SBRT to pancreatic and liver tumors.
Understand the toxicities associated with SBRT treatment of pancreatic and liver lesions.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Minnesota Medical Association and the Radiosurgery Society. The Minnesota Medical Association (MMA) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
The Minnesota Medical Association designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Board of Radiology SA-CME Self-Assessment Credit
The Radiosurgery Society Self-Assessment Module (SAM) titled Stereotactic Body Radiotherapy for the Treatment of Locally Advanced Pancreatic Cancer and Colorectal Liver Metastasis is qualified by the American Board of Radiology in meeting the criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification Program and has been qualified for 1.0 SAM credits. The ABR qualified this SAM on August 27, 2014.
Disclosure of Conflict of Interest
It is the policy of the Minnesota Medical Association (MMA) to ensure balance, independence, objectivity, and scientific rigor in its CME activities. To comply with the Standards for Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME), the MMA requires members of the planning committee and faculty to disclose the existence of any financial interest or other relationship he/she and his/her spouse or partner has with companies whose health care products or services are discussed in an educational presentation. The requirement applies to relationships that are in place at the time of the CME activity or in the 12 months preceding the activity.
The members of the faculty and planning committee for this conference have indicated that they have no relevant financial relationships to disclose related to the content of the CME activity.
Faculty members have declared that they will uphold the MMA’s standards regarding CME activities and that any clinical recommendations are based on the best available evidence or are consistent with generally accepted medical practice. Please indicate in the comments section of the evaluation form whether you detect any instances of bias toward products manufactured by commercial interests.
All individuals in a position to control the content of CE are listed below.
Joseph Herman, MD, MSc - no significant financial relationship(s) with business and industry.
Albert C. Koong, MD, PhD - no significant financial relationship(s) with business and industry.
Acknowledgement of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgement of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Certificate of Participation
A certificate will be issued upon completion of course requirements, including the evaluation, enabling you to register your credit with the appropriate licensing boards or associations.
A browser version of Internet Explorer 10.0 and higher or Firefox 3.0 or higher, Google Chrome Version 35 or higher.
A note on browser incompatibility:
We have tested IE 6.x in controlled configurations and we can stream successfully, but there are some versions that may not support the RTMP streams we push out - basically new technology that old technology can't handle.
Possible remedy: upgrade browser version, try alternate browsers such as Firefox.
Flash Player Version 11 or higher. If you have an older version it would be best to upgrade now. It's free and does not require a reboot. http://get.adobe.com/flashplayer
Windows Based Computer, Mac based Computers, smart phone, tablets
Windows Based Computer, Mac based Computers, smart phone, tablets
Windows XP SP 3 or Vista Home Premium or better
Mac OS x 10.5.3 or better
Pentium 4 or better
1meg of System Ram (Memory)
True Color 32 bit video card
Sound card and speakers
For more help with technical issues please click here.
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed on the RSS website under the title of the course.
Participants using RSS online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the RSS website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. The RSS reserves the right to remove a course before the end of its qualification period.